Loading clinical trials...
Loading clinical trials...
Validation of Biomarkers of Adverse Neurologic Outcome in Newborns at Risk for Perinatal Brain Injury - Study on Neuro-developmental Follow-up at 2 Years A Prospective Multicenter Observational Study for Development of a Diagnostic Test
Conditions
Locations
13
Germany
Städtisches Krankenhaus Aschaffenburg
Aschaffenburg, Germany
Universitätsklinikum Carl Gustav Carus, Neonatologie
Dresden, Germany
Uniklinik Essen
Essen, Germany
Marienkrankenhaus
Hamburg, Germany
Universitätsklinikum Heidelberg
Heidelberg, Germany
Städtisches Klinikum Karlsruhe, Klinik für Kinder- und Jugendmedizin
Karlsruhe, Germany
Start Date
February 5, 2019
Primary Completion Date
June 1, 2021
Completion Date
December 1, 2021
Last Updated
January 20, 2021
NCT06540222
NCT02572427
NCT03606278
NCT01866358
NCT00097097
Lead Sponsor
InfanDx AG
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions